08:30-08:55 | Vitallink symposium | Session 201+202 |
Vitallink symposium | ||
Moderator(s) | Sangil Min (Korea) | |
08:30-08:35 | Opening Remarks | Curie Ahn (Korea) |
08:35-08:40 | Congratulatory Address | Soon Il Kim (Korea) |
08:40-08:55 | 2018 Vitallink Report Summary | Curie Ahn (Korea) |
08:55-09:55 | Vitallink symposium 1 | Session 201+202 |
Potential Deceased Donor Management in Asia | ||
Moderator(s) | In Sung Moon (Korea), Nancy Ascher (USA) | |
08:55-09:10 | Potential brain death organ donors cases in Bangladesh | Jae-myeong Lee (Korea) |
09:10-09:25 | Brain death organ donor liver transplantation cases in Myanmar | Tin Tin Mar (Myanmar) |
09:25-09:40 | Potential brain death organ donors cases in India | Vivek B. Kute (India) |
09:40-09:55 | Potential brain death organ donors cases in Mongolia | Batchuluun Pandaan (Mongolia) |
09:55-10:20 | Coffee break | 300 B+C |
10:20-11:25 | Vitallink symposium 2 | Session 201+202 |
Life Sharing-Organ Transplantation Education for Teenagers & Medical Students | ||
Moderator(s) | Yeong Hoon Kim (Korea), Marcelo Cantarovich (Canada) | |
10:20-10:40 | Recent global progress in life sharing-organ transplantation education | Jeremy Chapman (Australia) |
10:40-10:55 | Role of the TTS in education on organ donation and transplantation for school children | Marcelo Cantarovich (Canada) |
10:55-11:10 | Experience in the development of teenager school education program | Jieun Oh (Korea) |
11:25-12:30 | Vitallink symposium 3 | Session 201+202 |
Public Awareness and Respectful attitudes towards the donor and the familyrespectful treatment | ||
Moderator(s) | Samuel Lee (Korea), Khin Maung Htay (Myanmar) | |
11:25-11:40 | How to Honor Organ Donor and their Family | Sunyoung Son (Korea) |
11:40-12:00 | Recent Progress for the Spread of Donation Culture in Australia | Philip O'Connell (Australia) |
12:00-12:15 | Public Promotion Activities in Mongolia | Battsetseg Gonchigjav (Mongolia) |
12:15-12:30 | Non-financial way of expressing respect for donor family | Nancy Ascher (USA) |
12:30-13:30 | Luncheon symposium 1 (GC Pharma) | Session 201+202 |
Moderator(s) | Dong-Lak Choi (Korea) | |
12:30-13:30 | Hepatitis B Immunoglobulin Prophylaxis after Liver Transplantation | Joo-Dong Kim (Korea) |
12:30-13:30 | Luncheon symposium 2 (Sanofi Genzyme) | Session 203+204 |
Moderator(s) | Yeong Hoon Kim (Korea) | |
12:30-13:30 | Hot topics in Kidney transplantation | Dorry Segev (USA) |
13:30-15:00 | PG course 1 (Kidney) | Session 201+202 |
What's hot in clinical and anatomical pathology | ||
Moderator(s) | Yong Jin Kim (Korea), Jong Soo Lee (Korea) | |
13:30-14:00 | NGS application for HLA typing or Higher resolution of HLA typing - is it necessary for organ transplant | Younhee Park (Korea) |
14:00-14:30 | Clinical Relevance of Non-HLA antibodies | Kyu Ha Huh (Korea) |
14:30-15:00 | Evolving criteria for the diagnosis of antibody-mediated rejection in kidney allografts | Kazuho Honda (Japan) |
13:30-15:00 | PG course 2 (Basic) | Session 203+204 |
Innate T lymphocytes: development and activation | ||
Moderator(s) | Tae Jin Kim (Korea) | |
13:30-14:00 | Development of innate T lymphocytes | You Jeong Lee (Korea) |
14:00-14:30 | Innate and adaptive Gamma-delta T cells | Tae Jin Kim (Korea) |
14:30-15:00 | Transcription factors in T cell activation and development | Yoontae Lee (Korea) |
13:30-15:30 | PG course 3 (교육위원회) | Session 205+206 |
Pharmacological update in solid organ transplant patients | ||
Moderator(s) | Sang Il Kim (Korea) | |
13:30-13:50 | Current trends of immunosuppressive agents after organ transplantation | Jae Geun Lee (Korea) |
13:50-14:10 | Prophylaxis protocol for post-transplant opportunistic infection | Kyungmin Huh (Korea) |
14:10-14:30 | Perioperative immunization for organ transplant recipient | Jonghun Kim (Korea) |
14:30-14:50 | Antiviral agents against viral hepatitis after solid organ transplantation | Young Youn Cho (Korea) |
14:50-15:00 | Q & A | |
15:00-15:30 | Coffee break | 300B+C |
15:30-17:00 | PG course 4 (Kidney) | Session 201+202 |
Managing the metabolic complication in kidney transplantation | ||
Moderator(s) | Chang-Kwon Oh (Korea), Joong Kyung Kim (Korea) | |
15:30-16:00 | Management and prevention of obesity after kidney transplantation | Cheng-Hsu Chen (Taiwan) |
16:00-16:30 | Efficacy and safety of new antidiabetic drugs in kidney transplant recipients | Byung Ha Chung (Korea) |
16:30-17:00 | Update of post-transplant bone disease: hyperparathyroidism, osteoporosis, and avascular necrosis | Gang-Jee Ko (Korea) |
15:30-17:00 | PG course 5 (Liver) | Session 203+204 |
Roads to be an expert: This is the way I developed myself | ||
Moderator(s) | Hee Jung Wang (Korea), Ki-Hun Kim (Korea) | |
15:30-15:50 | Living donor hepatectomy | Kenneth Siu Ho Chok (Hong Kong) |
15:50-16:10 | Recipient hepatectomy | Toru Ikegami (Japan) |
16:10-16:30 | Bench surgery and outflow reconstruction | Dong-Hwan Jung (Korea) |
16:30-16:50 | Artery anastomosis | Dong-Sik Kim (Korea) |
16:50-17:00 | Discussion | |
15:30-17:00 | PG course 6 (교육위원회) | Session 205+206 |
Natural course of living donor | ||
Moderator(s) | Hyung Joon Ahn (Korea) | |
15:30-15:50 | Postoperative complications in living donor | Jae Do Yang (Korea) |
15:50-16:10 | Social activity and support for living donors/td> | Ik Jin Yun (Korea) |
16:10-16:30 | Natural course of living kidney donors | Sik Lee (Korea) |
16:30-16:50 | Natural course of living liver donors | Jin Yong Choi (Korea) |
17:00-17:30 | KST Board Meeting | Session 201+202 |
17:30-19:00 | WIT Session & Network Event | Session 203+204 |
Moderator(s) | Curie Ahn (Korea), Yeong Hoon Kim (Korea) | |
17:30-17:40 | Woman in Transplantation: Sharing Malaysian experience | Rosnawati Yahya (Malaysia) |
17:40-17:50 | Mongolian Womans in Transplantation | Lkhaakhuu Od-erdene (Mongolia) |
17:50-18:00 | Discussion: The Impact of Mentorship | Khin Thida Thwin (Myanmar) |
18:00-18:10 | WIT Presentation and Thank You | Yeong Hoon Kim (Korea) |
18:10-19:00 | Networking Event |
08:00-08:30 | Opening Ceremony | Session 300A |
08:30-09:30 | Keynote Lecture 1 (Kidney/Thoracic) | Session 300A |
Moderator(s) | Jeremy Chapman (Australia), Jongwon Ha (Korea) | |
08:30-09:00 | Expanding the donor pool with expanded criteria and other risk donors | Marcelo Cantarovich (Canada) |
09:00-09:30 | Chronic lung allograft dysfunction | Lianne Singer (Canada) |
09:30-10:30 | Plenary Session 1 (Best Papers) | Session 300A |
Moderator(s) | Philip O'Connell (Australia), Jae-Won Joh (Korea) | |
09:30-09:45 | Self in vivo production of a synthetic biological drug anti-CD25/IL-10 using minicircle vector | YooJin Shin (Korea) |
09:45-10:00 | Progressive Chronic Kidney Disease Depending on Renal Recovery after Living Kidney Donation | Yaerim Kim (Korea) |
10:00-10:15 | Ischemia-free liver transplantation facilitates successful transplantation of extended criteria donor livers | Shanzhou Huang (China) |
10:15-10:30 | The Long-term Efficacy of de novo Everolimus Immunosuppression to Prevent Cardiac Allograft Vasculopathy in Heart Transplant Recipients | Hyo-In Choi (Korea) |
10:30-10:50 | Coffee break | 300 B+C |
10:50-11:10 | KST General Assembly | Session 300A |
11:10-12:10 | KST 50th Anniversary Ceremony | Session 300A |
12:10-13:00 | Luncheon symposium 3 (Astellas) | Session 300A |
Moderator(s) | Chang-Kwon Oh (Korea), Jong Soo Lee (Korea) | |
12:40-13:30 | Discussing Current Concerns on dnDSA, and The Association with TAC Level Variance and Adherence | Daniel Seron (Spain) |
13:00-14:30 | Concurrent Symposium 1 (Kidney) | Session 201+202 |
Liver The concept of coming back : Ischemic reperfusion injury in kidney transplantation | ||
Moderator(s) | Sang-Ho Lee (Korea), Cheng-Hsu Chen (Taiwan) | |
13:00-13:30 | Primary non-function and delayed graft function after kidney transplantation | Sangil Min (Korea) |
13:30-14:00 | Update on ischemia-reperfusion injury in kidney transplantation | Ju-Young Moon (Korea) |
14:00-14:30 | Clinical application of machine perfusion in kidney transplantation | Suphamai Bunnapradist (USA) |
13:00-14:30 | Concurrent Symposium 2 (Liver) | Session 203+204 |
Liver transplantation in patients with portal flow insufficiency | ||
Moderator(s) | Clark Andrew Bonham (USA), Shin Hwang (Korea) | |
13:00-13:20 | Management of portal hypertension and thrombosis in patients awaiting LT | Bo Hyun Kim (Korea) |
13:20-13:40 | Technical tip of portal vein thrombectomy during operation | Toshimi Kaido (Japan) |
13:40-14:15 | Alternative reconstruction methods using vessels other than the portal vein | Deok-bog Moon (Korea) |
14:15-14:30 | Video case presentation | Young Seok Han (Korea) |
Discussants | Dong Jin Joo (Korea), Je Ho Ryu (Korea), Chih-chi Wang (Taiwan), Kenneth Siu Ho Chok (Hong Kong) | |
13:00-14:30 | Concurrent Symposium 3 (Lung) | Session 205+206 |
Chronic lung allograft dysfunction: a new consensus report of the ISHLT 2019 | ||
Moderator(s) | Dong Kwan Kim (Korea), Moo Suk Park (Korea) | |
13:00-13:30 | Review of the consensus report of CLAD 2019 | Lianne Singer (Canada) |
13:30-13:45 | Pathologic view point of CLAD | Beom Jin Lim (Korea) |
13:45-13:55 | Cases of institutional experience | Woo Hyun Cho (Korea) |
13:55-14:05 | Cases of institutional experience | Song Yee Kim (Korea) |
14:05-14:30 | Panel discussion and Q&A | Kyeongman Jeon (Korea), Jieun Park (Korea), Sung-Hoon Park (Korea) |
14:30-15:30 | Oral presentation 1 (Kidney) | Session 201+202 |
Moderator(s) | Soo Jin Na Choi (Korea), Yeong Hoon Kim (Korea) | |
14:30-14:42 | Association between adherence and intra-patient variability in tacrolimus concentration among kidney transplant recipients: a post hoc analysis of the PRIMA randomized clinical trial | Hyunmin Ko (Korea) |
14:42-14:54 | Urinary exosomal hemopexin, a validated diagnostic marker for rejection in kidney transplant recipients | Jeong-Hoon Lim (Korea) |
14:54-15:06 | Outcome of ABO incompatible kidney transplantation in the elderly: a national cohort study using Korean Organ Transplantation Registry data | Deok Gie Kim (Korea) |
15:06-15:18 | Cardiovascular disease after kidney transplantation: a nationwide study in South Korea | Ji Eun Kim (Korea) |
15:18-15:30 | Assessment of the usefulness of acute rejection specific transcripts signature in a prospective kidney transplantation cohort | Su Woong Jung (Korea) |
14:30-15:30 | Oral presentation 2 (Liver) | Session 203+204 |
Moderator(s) | Chinburen Jigjidsunren (Mongolia), Youngkyoung You (Korea) | |
14:30-14:42 | Real-World Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of KOTRY Database | Shin Hwang (Korea) |
14:42-14:54 | Impact of the baseline anti-A/B IgG titer on the clinical outcome in ABO-incompatible liver transplantation | Juhan Lee (Korea) |
14:54-15:06 | Decreased hepatocellular carcinoma recurrence effect of statins on the living donor liver transplantation patients | Okjoo Lee (Korea) |
15:06-15:18 | Silent allograft fibrosis in 10-year post-transplantation histology of pediatric liver transplantation: Is it really silent? | Seo Hee Lee (Korea) |
15:18-15:30 | Pure laparoscopic living donor hepatectomy : single-center experience on 300 patients | Eui Soo Han (Korea) |
14:30-15:30 | Oral presentation 3 (Thoracic) | Session 205+206 |
Moderator(s) | Eun-Seok Jeon (Korea), Jin Gu Lee (Korea) | |
14:30-14:42 | Primary Graft Dysfunction after isolated Heart Transplantation: Incidence, Risk Factors and Clinical Implications | Younju Rhee (Korea) |
14:42-14:54 | Role of Bronchoalveolar lavage fluid & Serum Aspergillus galactomannan as a predictor of invasive aspergillosis in lung transplantation recipients; A single center study | Seung Hyun Yong (Korea) |
14:54-15:06 | Prone position: a means of overcoming an oversized donor lung | Taehwa Kim (Korea) |
15:06-15:18 | Successful treatment of fatal hyperammonemia after lung transplantation | JIN OOK JANG (Korea) |
15:18-15:30 | Reconstituted trachea from the skin flap in the experimental lung transplant | Do Xuan Hai (Vietnam) |
15:30-16:30 | Coffee break | 300 B+C |
15:30-16:30 | Poster-oral Presentation 01 (Basic) | 300B+C |
Moderator(s) | Dong Ho Choi (Korea), Junho Chung (Korea) | |
15:30-15:40 | Systems Medicine Modeling, Stability Analysis and Computer Simulation of Hepatitis B Virus Spread by Vaccination | Rifaldy Fajar (Indonesia) |
15:40-15:50 | Protective effect of Eupatilin against Tacrolimus-induced Nephrotoxicity in LLC-PK1 cells | Hyuk Jai Jang (Korea) |
15:50-16:00 | Developing experiment for Microtube kit for rat microvascular surgery (MKRMS) facilitating rapid and accurate microvascular anastomosis | Sam-Youl Yoon (Korea) |
16:00-16:10 | Cytotoxicity of Human Hepatic Intrasinusoidal CD56bright Natural Killer Cells against Hepatocellular Carcinoma Cells | Shin Hwang (Korea) |
15:30-16:30 | Poster-oral Presentation 02 (Kidney) | 300B+C |
Moderator(s) | Seungyeup Han (Korea), Kyung Hwan Jeong (Korea) | |
15:30-15:40 | Reduced Fixed Dose of Mycophenolate Mofetil with Therapeutic Drug Monitoring in De Novo Renal Transplant Recipients | Jang-Hee Cho (Korea) |
15:40-15:50 | Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: A retrospective study | Deok Gie Kim (Korea) |
15:50-16:00 | Characteristics of kidney transplantation in South Korea from 2008 to 2016 | Sehoon Park (Korea) |
16:00-16:10 | Potential Urinary Proteomic Biomarkers of Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients | Hee-Yeon Jung (Korea) |
16:10-16:20 | Multiple Drug Resistant Urinary Tract Infection in Kidney Transplant Recipients: A Retrospective Cohort Study | Muhammad Tassaduq Khan (Pakistan) |
15:30-16:30 | Poster-oral Presentation 03 (Kidney) | 300B+C |
Moderator(s) | Chan-Duck Kim (Korea), Hyung Tae Kim (Korea) | |
15:30-15:40 | Early rise of urinary exosomal BK virus microRNA as a predictive marker for BK virus nephropathy in a prospective kidney transplantation cohort | Won Hee Cho (Korea) |
15:40-15:50 | Clinical significance of late antibody-mediated rejection without donor-specific anti- HLA antibodies | Juhan Lee (Korea) |
15:50-16:00 | Long-term exposure to particulate matter air pollution and the risk of graft failure and mortality in kidney transplant recipients | Yong Chul Kim (Korea) |
16:00-16:10 | Universal Prophylaxis with Valganciclovir versus Preemptive Therapy in Minimizing the Risk of Cytomegalovirus Infection and Disease in High and Intermediate Risk Kidney Transplant Recipients: A Single-centered Experience | Muhammad Tassaduq Khan (Pakistan) |
16:10-16:20 | Pharmacokinetics Clearance of Tacrolimus in Renal Transplant Recipients at Mandalay General Hospital | Yi Yi Htun (Myanmar) |
16:20-16:30 | Effectiveness of serum beta-2 microglobulin as a tool to evaluate kidney status | In Sik Shin (Korea) |
15:30-16:30 | Poster-oral Presentation 04 (Kidney) | 300B+C |
Moderator(s) | Myung-gyu Kim (Korea), JeongKye Hwang (Korea) | |
15:30-15:40 | The Korean Organ Transplantation Registry (KOTRY): First Official Kidney Transplantation Report | Tai Yeon Koo (Korea) |
15:40-15:50 | Effectiveness of an early CMV screening protocol in Thai kidney transplant patients with moderate risk for CMV infection: A preliminary report | Nartsiri Ratchawang (Thailand) |
15:50-16:00 | Effect of intra-patient variability of tacrolimus level on allograft outcomes in Thai kidney transplant patients | Nuttasith Larpparisuth (Thailand) |
16:00-16:10 | Urinary NGAL in living kidney donors during long-term follow up; risk of CKD is low | Joon Chae Na (Korea) |
16:10-16:20 | Malignancy in Kidney Transplant Recipients | Than Aye (Myanmar) |
15:30-16:30 | Poster-oral Presentation 05 (Kidney) | 300B+C |
Moderator(s) | Dong Ryeol Lee (Korea), Sun Cheol Park (Korea) | |
15:30-15:40 | Usefulness of pharmacokinetic model based tacrolimus dosing in kidney transplant patients with genetic subgroup analysis | Hyokee Kim (Korea) |
15:40-15:50 | Laparoscopic living donor right nephrectomy: Assessment of outcome and association of BMI to length of right renal vein | VU LE NGUYEN (Vietnam) |
15:50-16:00 | Laparoscopic Donor Nephrectomy(Where are we?) | Aung Kyaw Tun (Myanmar) |
16:00-16:10 | Impact of pre-transplant BK viral replication on post-transplant BK viremia in renal transplant recipients | Hyejin Mo (Korea) |
16:10-16:20 | Incidence, Characteristics and Management of Chronic Active Antibody Mediated Rejection among Kidney Transplant Patients at National Kidney and Transplant Institute from (NKTI) 2005-2016 | SUSAN FLORES-LABUNTOG (Philippines) |
16:20-16:30 | Effect on Dosage Change and Intrapatient Variability of Tacrolimus Level after Conversion from Mycophenolic Acid to Everolimus among Thai Kidney Transplant Patients with and without CYP3A4/5 Inhibitors | Nuttasith Larpparisuth (Thailand) |
15:30-16:30 | Poster-oral presentation 06 (Liver) | 300B+C |
Moderator(s) | Bong-Wan Kim (Korea), Deok-bog Moon (Korea) | |
15:30-15:40 | Portal vein thrombosis during liver transplantation: The risk of extra-anatomical portal vein reconstruction | Jinsoo Rhu (Korea) |
15:40-15:50 | Hepatitis B Vaccination and Entecavir Monotherapy Following Withdrawal of Hepatitis B Immunoglobulin. An Alternative Approach to Prevention of Hepatitis B Reactivation After Liver Transplantation | Hye Sung JO (Korea) |
15:50-16:00 | Long-term Metabolic Complications in Patients Undergoing Liver Transplantation: A Survey of 651 Cases at a Tertiary Referral Center | Mohssen Nassiri Toosi (Iran) |
16:00-16:10 | Subclassification of microscopic vascular invasion in hepatocellular carcinoma | Incheon Kang (Korea) |
16:10-16:20 | Umbelliferone loaded Nano-Lipidic Carriers regulates mitochondrial apoptosis and PhD2 mediated hypoxia in Diethyl nitrosamine induced Hepatocellular Carcinoma | Vikas Kumar (India) |
15:30-16:30 | Poster-oral Presentation 07 (Liver) | 300B+C |
Moderator(s) | Jai Young Cho (Korea), Young Seok Han (Korea) | |
15:30-15:40 | A novel approach to the management of hepatic artery intimal dissection during living donor liver transplantation | Naganathan Selvakumar (India) |
15:40-15:50 | Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy | Jae Geun Lee (Korea) |
15:50-16:00 | Novel technique for graft reduction of left lateral segment: Medial Reduction for pediatric liver transplant recipient | Yoshihiro Hirata (India) |
16:00-16:10 | Incidentally diagnosed abdominal tuberculosis intraoperatively in liver transplant recipients during Living Donor Liver Transplantation (LDLT) | Smita Parakh (India) |
16:10-16:20 | Circulating cancer stem cells in hepatocellular carcinoma: a pilot study of prediction for tumor recurrence after living donor liver transplantation | Hyeo Seong Hwang (Korea) |
16:20-16:30 | Solid lipid nanoparticle of hesperidine exerts diethylnitrosamine/phenobarbitalinduced hepatocellular carcinoma via alteration of PI3K/Akt pathway | Deepika Singh (India) |
15:30-16:30 | Poster-oral Presentation 08 (Liver) | 300B+C |
Moderator(s) | Donglak Choi (Korea), Dong-Sik Kim (Korea) | |
15:30-15:40 | Analysis of Biliary Complications following Liver Transplantation: A 16-years Experience at a High-volume Transplant Center | Nasir Fakhar (Iran) |
15:40-15:50 | Clinical differences between steroid sensitive rejection and steroid resistant rejection in liver transplantation | Tae Yun Lee (Korea) |
15:50-16:00 | Addition of Metformin to Tacrolimus may improve the Treg/Th17 balance compared to Tacrolimus monotherapy in vitro analysis | Soon Kyu Lee (Korea) |
16:00-16:10 | Survival benefits of living donor liver transplantation for low MELD patients | Tiffany Wong (Hong Kong) |
16:10-16:20 | Liver transplantation for acute liver failure associated with herbal medicine | Tracy YS Cui (Hong Kong) |
15:30-16:30 | Poster-oral Presentation 09 (Donation) | 300B+C |
Moderator(s) | Namkyu Choi (Korea), Jae-myeong Lee (Korea) | |
15:30-15:40 | The Effect of "Opt-out" System for Organ Donation after Brain Death on Ethical Legitimacy and Potential Efficacy in a Mathematical Model | Young-Nam Roh (Korea) |
15:40-15:50 | A survey on Awareness and Attitude Regarding Organ Donation among Medical Professionals, Medical students, Patients and their relatives in Bangladesh | A.S.M. Tanim Anwar (Bangladesh) |
15:50-16:00 | Expanding Brain death donor transplantation in Mongolia | Battsetseg Gonchigjav (Mongolia) |
16:00-16:10 | Living kidney donors with metabolic risk has been increasing in South Korea | Eunjeong Kang (Korea) |
15:30-16:30 | Poster-oral Presentation 10 (Thoracic) | 300B+C |
Moderator(s) | Jae-Joong Kim (Korea), Do Hyung Kim (Korea) | |
15:30-15:40 | Successful lung transplantation in patient with heparin induced thrombocytopenia with thrombosis during extracorporeal membrane oxygenation | Hye Ju Yeo (Korea) |
15:40-15:50 | First Heart Transplantation at EWHA Medical Center | Kyung Jin Kim (Korea) |
15:50-16:00 | Analysis about the results of cross-matching and anti-HLA antibodies before lung trasplantatoin | Song Yee Kim (Korea) |
16:00-16:10 | No more contraindication in special conditions: Clinical midterm outcome of adult heart transplantation using Hepatic C Virus seropositive donors for seronegative recipients | Chuan-I Tsao (Taiwan) |
16:10-16:20 | Combined trido-lung and kidney transplantation in a patient with rejection and chronic kidney disease after previous redo-lung transplantation | Jin-hee Noh (Korea) |
16:30-17:30 | Concurrent Symposium 4 (Kidney) | Session 201+202 |
How to improve the outcome of Pediatric kidney transplantation | ||
Moderator(s) | Ik Jin Yun (Korea), Min Hyun Cho (Korea) | |
16:30-16:50 | Recurrent FSGS in Pediatric KT | Min Hyun Cho (Korea) |
16:50-17:10 | DSA and epitope matching in Pediatric KT | Borae G. Park (Korea) |
17:10-17:30 | Lower urinary tract problems in Pediatric KT | Young Jae Im (Korea) |
16:30-17:30 | Concurrent Symposium 5 (Liver) | Session 203+204 |
Special considerations in pediatric liver transplantation | ||
Moderator(s) | Carlos O. Esquivel (USA), Suk Koo Lee (Korea) | |
16:30-16:50 | Donor and graft selection to overcome large-for-size syndrome | Seisuke Sakamoto (Japan) |
16:50-17:10 | Special surgical techniques in pediatric liver transplantation | Carlos O. Esquivel (USA) |
17:10-17:30 | Case and discussion | Ping Wan (China) |
17:10-17:30 | Discussants | Nam-Joon Yi (Korea), Shin Hwang (Korea), Artem Monakhov (Russia) |
16:30-17:30 | Concurrent Symposium 6 (Heart) | Session 205+206 |
Chronic cardiac allograft rejection | ||
Moderator(s) | Jae-Joong Kim (Korea), Sung-Ho Jung (Korea) | |
16:30-16:45 | Mechanism of chronic cardiac allograft rejection | Jin Joo Park (Korea) |
16:45-17:00 | Diagnosis and management of chronic cardiac allograft rejection | Soo Yong Lee (Korea) |
17:00-17:10 | Cases and experience | Darae Kim (Korea) |
17:10-17:20 | Cases and experience | Hyo-In Choi (Korea) |
17:20-17:30 | Panel discussion and Q&A | Ju Yong Lim (Korea), Mina Kim (Korea) |
18:00-20:00 | Welcome Dinner | Hwangnyongwon |
08:00-09:30 | Concurrent Symposium 7 (KSN Joint Session) | Session 201+202 |
Moderator(s) | Chul Woo Yang (Korea), Suphamai Bunnapradist (USA) | |
08:00-08:20 | Recurrent hydronephrosis. Why? How to manage? (이식후 반복적으로 요로결석이 생기는 경우에 고려해야할 사항과 치료방법) |
Hyung Duk Kim (Korea) |
08:20-08:40 | Asymptomatic bacteriuria. Why? How to manage? (무증상의 세균뇨가 나오는 경우 치료방법과 실제로 치료해도 계속나오는 경우의 대처) |
Kyo Won Lee (Korea) |
08:40-09:00 | Hypertensive living donor renal transplantation | Hyeon Seok Hwang (Korea) |
09:00-09:20 | Bactrim prophylaxis. How much and how long? (이식초기에 PJP예방을 위한 bactrim투여기간, 용량 및 기타 적응증과 기간) |
In O Sun (Korea) |
09:20-09:40 | Discussion | |
08:00-09:30 | KOTRY Joint Session | Session 203+204 |
Moderator(s) | Myoung Soo Kim (Korea), Jaeseok Yang (Korea) | |
08:00-08:30 | Allocation of deceased donor kidneys in Australia | Phil Clayton (Australia) |
08:30-09:00 | Lesson from large-scale genomic studies and research consortia | Joon-Yong An (Korea) |
09:00-09:15 | Making registry for harmonization in Asian transplant society: Current progress in ASTREG | Kenji Yuzawa (Japan) |
09:15-09:30 | Making registry for harmonization in Asian transplant society: Current progress in ASTREG | Jong Cheol Jeong (Korea) |
08:00-09:30 | Concurrent Symposium 8 (Basic) | Session 205+206 |
Moderator(s) | Kyungho Choi (Korea), Hyori Kim (Korea) | |
08:00-08:30 | Regulation of CD8 T cell response for mouse minor histocompatibility antigens | Eun Young Choi (Korea) |
08:30-09:00 | Regulation of high affinity Ab production: a possible role in Ab-mediated rejection | Youn Soo Choi (Korea) |
09:00-09:30 | Antibody responses in autoimmune diseases | Jeehee Youn (Korea) |
09:30-10:30 | Concurrent Symposium 9 (Pancreas/Islet) | Session 201+202 |
Recent updates in Pancreas Transplantation | ||
Moderator(s) | Jae Berm Park (Korea), Young Hoon Kim (Korea) | |
09:30-09:50 | Updates in surgical technique | Rune Horneland (Norway) |
09:50-10:10 | Diagnosis of Rejection in Pancreas Transplantation | Byunghyun Choi (Korea) |
10:10-10:30 | Metabolic improvement after Pancreas Transplantation | Sung Shin (Korea) |
09:30-10:30 | Oral presentation 4 (Coordination) | Session 203+204 |
Moderator(s) | Bok Nyeo Kim (Korea), Hyun Jung Kim (Korea) | |
09:30-09:42 | 뇌사 장기 기증자와 인체 조직 기증자에게 지급된 실제 국가 지원금 | Eunsil Jeong (Korea) |
09:42-09:54 | Low adherence to immunosuppressants is associated with alcohol drinking among liver transplant recipients | Kyung Ock Jeon (Korea) |
09:54-10:06 | 장기이식수혜자의 건강문해력과 건강관련 삶의 질 간의 관계 | Sunyoung Son (Korea) |
10:06-10:18 | 신장이식 환자에서 이식 전 후 근력의 변화 | TAEHEE KIm (Korea) |
10:18-10:30 | 신장이식환자의 나트륨 섭취량 측정 | Sun Young Oh (Korea) |
09:30-10:30 | Oral Presentation 5 (Basic/Others/Pancreas/Islet) | Session 205+206 |
Moderator(s) | Ik Jin Yun (Korea), Yeong Jin Choi (Korea) | |
09:30-09:42 | Hepatocellular carcinoma research platform from patient-derived xenograft to organoid toward biobanking for precision medicine | Shin Hwang (Korea) |
09:42-09:54 | Ethical issues for uterine transplantation | Evie Kendal (Australia) |
09:54-10:06 | The predictive value of real-time elastography in the risk of pancreatic fistula after pancreaticoduodenectomy | Yu Cheng (China) |
10:06-10:18 | The therapeutic efficacy of water soluble coenzyme Q10 in experimental model of tacrolimus induced diabetes mellitus | YI QUAN (Korea) |
10:18-10:30 | New approaches for predicting tacrolimus-induced diabetes after transplantation using patient-specific progenitor pancreatic cells from iPSC | Sun Woo Lim (Korea) |
10:30-11:00 | Coffee break | 300B+C |
11:00-12:00 | Keynote lectures 2 (Liver/Basic) | Session 300A |
Moderator(s) | Junho Chung (Korea), Soon Il Kim (Korea) | |
11:00-11:30 | Bridging therapies to liver transplantation for HCC within the Milan Criteria | Francois Durand (France) |
11:30-12:00 | Evolution of non-MHC Tissue Transplantation | Derry Roopenian (USA) |
12:30-13:30 | Luncheon Symposium 4 (Chong Kun Dang Pharm.) | Session 201+202 |
Moderator(s) | Yu Seun Kim (Korea), Chang-Kwon Oh (Korea) | |
12:30-13:00 | Safety and efficacy of the step-wise reduction of immunosuppression after kidney transplantation, and its effect on the glucose metabolism | Su Hyung Lee (Korea) |
12:30-13:30 | Luncheon Symposium 5 (Novartis Korea) | Session 203+204 |
Moderator(s) | Hwang, Shin (Korea) | |
12:30-13:30 | Which is the most fittable IS regimen strategy with current status of liver allocation? | Jae Geun Lee (Korea) |
13:30-14:30 | Plenary session 2 | Session 300A |
Moderator(s) | Suk Koo Lee (Korea), Hong Rae Cho (Korea) | |
13:30-14:00 | Kidney organoid in translational medicine | Ryuji Morizane (USA) |
14:00-14:30 | Marginal Grafts in Living Donor Liver Transplantation | Kyung-Suk Suh (Korea) |
10:30-11:00 | Coffee break | 300B+C |
14:30-15:30 | Poster-oral Presentation 11 (Kidney) | 300B+C |
Moderator(s) | Kyu Ha Huh (Korea), Beom Seok Kim (Korea) | |
14:30-14:40 | Improved Serum Vitamin D level and better cardiovascular disease outcomes after Kidney Transplantation | JungHwa Ryu (Korea) |
14:40-14:50 | Mycophenolic Acid Trough Concentration and Dose are associated with Hematologic Abnormalities but not with Rejection in Kidney Transplant Recipients | Hye Won Lee (Korea) |
14:50-15:00 | Changes in plasma metabolites after conversion from cyclosporine to tacrolimus in long-term stable kidney transplant recipients | Ji-Young Choi (Korea) |
15:00-15:10 | Efficacy and safety of percutaneous embolization compared with nephrectomy to treat graft intolerance syndrome in late graft failure patients | Su-kyung Kwon (Korea) |
14:30-15:30 | Poster-oral Presentation 12 (Kidney) | 300B+C |
Moderator(s) | Jung Hwan Park (Korea), Samuel Lee (Korea) | |
14:30-14:40 | Late intra-patient tacrolimus variability predicts de novo donor-specific antibody and graft loss | Juhan Lee (Korea) |
14:40-14:50 | Validation of Genetic Polymorphism for New-Onset Diabetes after Renal Transplantation | Hyeon Seok Hwang (Korea) |
14:50-15:00 | Diagnosis and Immune Modulation for Bk Virus Infection Should Consider Activated T Cell Level, Cytokines Level, and Primary Disease | WEN YAO YIN (Taiwan) |
14:30-15:30 | Poster-oral Presentation 13 (Kidney) | 300B+C |
Moderator(s) | Sunwoo Kang (Korea), Sun Hyung Joo (Korea) | |
14:30-14:40 | Tertiary lymphoid tissues in protocol biopsies predict progressive graft dysfunction in kidney transplant recipients | Yu Ho Lee (Korea) |
14:40-14:50 | The influence of the donor kidney weight to recipient body weight on long-term renal graft outcomes | Seok Jeong Yang (Korea) |
14:50-15:00 | Therapeutic potential of coenzyme Q10 in mitochondrial dysfunction during tacrolimus-induced beta cell injury | Kang Luo (Korea) |
15:00-15:10 | Prevalence of depression in kidney transplant recipients: a long-term population-based study | Semin Cho (Korea) |
15:10-15:20 | Health-related quality of life in kidney transplant patients was better than those in chronic kidney disease patients at similar renal function | JungHwa Ryu (Korea) |
15:20-15:30 | Delayed Graft Function in Kidney Transplants from Deceased Donors with Acute Kidney Injury | Chris Tae Young Chung (Korea) |
14:30-15:30 | Poster-oral Presentation 14 (Kidney) | 300B+C |
Moderator(s) | Borae G. Park (Korea), Ji Il Kim (Korea) | |
14:30-14:40 | The tacrolimus metabolism affect post-transplant outcome mediating acute rejection and delayed graft function: analysis from Korean Organ Transplantation Registry (KOTRY) data | Jong Cheol Jeong (Korea) |
14:40-14:50 | Assessment of delta-neutrophil index in living kidney donors: toward understanding the pathogenesis of renal function recovery | Jee Soo Park (Korea) |
14:50-15:00 | Long term graft outcome after subclinical Banff borderline changes suspicious for acute T cell-mediated rejection | Ahram Han (Korea) |
15:00-15:10 | Outcome of Living Kidney donors with Microproteinuria: expanding the donor criteria | Joon Chae Na (Korea) |
15:10-15:20 | Bisphosphonate Use Leads to Better Long-Term Kidney Transplant Outcomes | HOON YOUNG CHOI (Korea) |
14:30-15:30 | Poster-oral Presentation 15 (Liver) | 300B+C |
Moderator(s) | Jong Man Kim (Korea), Geun Hong (Korea) | |
14:30-14:40 | Necessity and effect of perioperative renal replacement therapy in high MELD score patients waiting for deceased donor liver transplantation | Shin Hwang (Korea) |
14:40-14:50 | Effects of tenofovir and entecavir on glomerular kidney function in liver transplant patients: a nationwide cohort study | Juhan Lee (Korea) |
14:50-15:00 | Dual-graft adult living donor liver transplantation with both graft Duct-to-Duct biliary anastomosis : Short-term and long-term outcomes | Yong-Kyu Chung (Korea) |
15:00-15:10 | Venous outflow congestion is related to poor recur-free survival of hepatocellular carcinoma patients who underwent living donor liver transplantation | Jinsoo Rhu (Korea) |
14:30-15:30 | Poster-oral Presentation 16 (Liver) | 300B+C |
Moderator(s) | Jae Do Yang (Korea), Kwang-Woong Lee (Korea) | |
14:30-14:40 | Various technique for bile duct division in pure laparoscopic donor hepatectomy | Jeong-Moo Lee (Korea) |
14:40-14:50 | Clinical Application of Neutrophil to Lymphocyte Ratio in predicting 3-month Mortality among Cirrhotic Patients on the Liver Transplant Waiting List: A Cohort Study | Mohssen Nassiri Toosi (Iran) |
14:50-15:00 | Image-guided surgery based on 2D illustrations and 3D printed model of donor anatomy during living donor hepatectomy | Jinsoo Rhu (Korea) |
15:00-15:10 | Renal safety of entecavir and tenofovir with hepatitis B immunoglobulin in liver transplant patients | Juhan Lee (Korea) |
15:10-15:20 | Hepatic Progenitor Cells as Predictors of Response to Antiviral Therapy in Chronic Hepatitis C Viral Infection | Aly Kassem (Egypt) |
15:20-15:30 | Transplantable bile duct seeded with cholangiocytes derived from human chemically derived liver progenitor cells | Elina Maria Buisson (Korea) |
14:30-15:30 | Poster-oral Presentation 17 (Liver) | 300B+C |
Moderator(s) | Gi Hong Choi (Korea), Jeong Won Jang (Korea) | |
14:30-14:40 | Validation of ADV Score as a Quantifiable Prognostic Biomarker for Hepatocellular Carcinoma Recurrence After Liver Transplantation | Shin Hwang (Korea) |
14:40-14:50 | Living donor liver transplant for ACLF3 is challenging but has similar and acceptable outcomes | Sapana Verma (India) |
14:50-15:00 | Pure laparoscopic versus open right hepatectomy in live liver donors: a propensity score matched analysis | Suk Kyun Hong (Korea) |
14:30-15:30 | Poster-oral Presentation 18 (Others) | 300B+C |
Moderator(s) | Jang-Hee Cho (Korea), Kyung Hwan Jeong (Korea) | |
14:30-14:40 | Effects of Short-term Preservation Solutions on the Viability and Potency of Canine Adipose-Derived Mesenchymal Stem Cells | Tania Sultana (Korea) |
14:40-14:50 | Effect of Gymnema sylvestre on pancreatic β-cell regeneration | Senthil Kumar Subramani (India) |
14:50-15:00 | Public awareness survey on Organ Donation and Transplantation | Battsetseg Gonchigjav (Mongolia) |
15:00-15:10 | Differential characteristics of recipients with non-infectious fever following pancreas transplantation with antithymocyte globulin induction | Ye Eun Shim (Korea) |
15:10-15:20 | Association of Antibody-secreting Cells with Allograft Rejection in Kidney Transplantation | Minjeong Nam (Korea) |
15:20-15:30 | Validation of Rapid Optimized Flow Cytometric Crossmatch Assay | Sangyoon Lee (Korea) |
14:30-15:30 | Poster-oral Presentation 19 (Coordination) | 300B+C |
Moderator(s) | Hyung Sook Kim (Korea), Jaesook Oh (Korea) | |
14:30-14:40 | 사회문제와 언론 보도가 기증희망등록과 실제 기증에 미치는 영향 | Jungsun Kim (Korea) |
14:40-14:50 | 통보된 뇌사추정자의 관리현황과 기증 증가를 위한 방안 | Eunsuk Yu (Korea) |
14:50-15:00 | 단일 종합병원 뇌사자 신장이식수혜자의 대기기간과 매칭빈도수 분석 | JUNG JA HONG (Korea) |
15:30-16:30 | Concurrent Symposium 10 (Xenotransplantation) | Session 201+202 |
Moderator(s) | Nam Hyung Kim (Korea), Curie Ahn (Korea) | |
15:30-15:45 | Status of Xenotransplantation for 20 years in Korea | Curie Ahn (Korea) |
15:45-16:00 | Current status of Clinical Pancreatic Islet Xenotransplantation | Chung-Gyu Park (Korea) |
16:00-16:15 | Improvement safety and efficiency of xeno islet transplantation | Hyojun Park (Korea) |
16:15-16:30 | Ethical and legal aspect of the xenotransplantation | So Yoon Kim (Korea) |
15:30-15:50 | Update 1 (Liver) | Session 203+204 |
Small bowel transplantation | ||
Moderator(s) | Myoung Soo Kim (Korea) | |
15:30-15:50 | Update on intestinal transplantation | Clark Andrew Bonham (USA) |
15:50-16:30 | Concurrent Symposium 11 (Liver) | Session 203+204 |
Medical management for liver transplantation | ||
Moderator(s) | Hee Chul Yu (Korea), Francois Durand (France) | |
15:50-16:10 | Management of HCV in pre- and post-transplant situation | W. Ray Kim (USA) |
16:10-16:30 | Systemic therapy for HCC in liver transplantation | Jeong Won Jang (Korea) |
15:50-16:30 | Concurrent Symposium 12 (Coordination) | Session 205+206 |
Moderator(s) | In Ok Kim (Korea), In-hye Song (Korea) | |
15:30-15:50 | Processes and problems for the management of brain death donor | Yong Min Lee (Korea) |
15:50-16:10 | Review of living organ transplantation approval procedures | Jieun Lee (Korea) |
16:10-16:20 | Q & A | |
16:20-16:30 | Assembly | In Ok Kim (Korea) |
16:30-17:30 | Award Ceremony and Closing | Session 201+202 |